Investors

Overview

KYTHERA (NASDAQ: KYTH) is a biopharmaceutical company that focuses on developing and commercializing high-demand medical aesthetics products. We target large-scale global opportunities to develop innovative drugs and medical devices to treat under-addressed aesthetic complaints. We look for market segments with both motivated patients and motivated physicians. Our longer-term strategy is to leverage our biotechnology and aesthetics experience to aggressively expand our product portfolio and pipeline.

TRANSFER AGENT

  • Sign up for email alerts
Subscribe Now